Pay in 4 interest-free payments of $6.11 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Tirzepatide is contraindicated in patients with medullary thyroid cancer
Rapid birth-death evolution and positive selection in detoxification-type glutathione S-transferases in mammals
Premium tier: $400 to $700 per month Premium pricing usually reflects enhanced formulations, more comprehensive medical oversight, or concierge-level service
View Retatrutide specifications Read the latest Retatrutide Phase 3 results Compare Retatrutide and Tirzepatide Request the current Retatrutide COA + a quote Sources and further reading Lilly: TRIUMPH-1 Phase 3 results Lilly: TRIUMPH-2 and TRIUMPH-3 results ClinicalTrials.gov: TRIUMPH-1 Frequently asked questions What are the most common retatrutide side effects
US$ 24.59
US$ 22.44
US$ 22.49
US$ 22.39
US$ 20.10
